Skip to main content

Prolactin and Autoimmunity: Influences of Prolactin in Systemic Lupus Erythematosus

  • Chapter
Advances in Psychoneuroimmunology

Abstract

The autoimmune disease, systemic lupus erythematosus (SLE), is incurable, and individuals with this illness are at risk of severe and potentially fatal involvement of the central nervous system and kidneys.1,2 SLE occurs most commonly in women of childbearing age, and evidence has suggested that this disease is influenced by reproductive hormones.3 Recent studies in this laboratory have employed a hormone-sensitive murine model of SLE, the NZB X NZW (B/W) mouse,4 to investigate the role of the lactotrope, prolactin,5,6 in spontaneously occurring autoimmune disease. This report will summarize our findings in groups of female B/W mice made hyperprolactinemic or, conversely, treated with bromocriptine, an inhibitor of prolactin secretion.7

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. N.F. Rothfield, Systemic lupus erythematosus, in: “Rheumatic Diseases, Diagnosis and Management,” W.A. Katz, ed., J.B. Lippincott Co., Philadelphia (1977).

    Google Scholar 

  2. W.H. Reeves and R.G. Lahita, Clinical presentation of systemic lupus erythematosus in the adult, in: “Systemic Lupus Erythematosus,” R. G. Lahita, ed., John Wiley & Sons, New York (1987).

    Google Scholar 

  3. J.S. Smolen and A.D. Steinberg, Systemic lupus erythematosus and pregnancy: clinical, immunological, and theoretical aspects, Prog. Clin. Biol. Res. 70:283 (1981).

    PubMed  CAS  Google Scholar 

  4. J.B. Howie and B.J. Helyer, The immunology and pathology of NZB mice, Adv. Immunol. 9:215 (1968).

    Article  PubMed  CAS  Google Scholar 

  5. C. Tougard and A. Tixier-Vidal, Lactotropes and gonadotropes, in: “The Physiology of Reproduction,” E. Knobil and J.D. Neill, eds., Raven Press, New York (1988).

    Google Scholar 

  6. R. McMurray, D. Keisler, K. Kanuckel, S. Izui and S.E. Walker, Prolactin influences autoimmune disease activity in the female B/W mouse, J. Immunol. 147:3780 (1991).

    PubMed  CAS  Google Scholar 

  7. D. Parkes, Bromocriptine, N. Engl. J. Med. 301:873 (1979).

    Article  PubMed  CAS  Google Scholar 

  8. R. W. McMurray, S.H. Allen, A. Braun and S.E. Walker, Longstanding hyperprolactinemia (HYPERPR) in systemic lupus erythematosus (SLE): possible hormonal stimulation of an autoimmune syndrome, Arthritis Rheum. 35(suppl) :S168 (1992).

    Article  Google Scholar 

  9. R.W. McMurray, S.H. Allen, A. Braun, F. Rodriguez and S.E. Walker, Longstanding hyperprolactinemia associated with systemic lupus erythematosus: possible hormonal stimulation of an autoimmune disease, J. Rheumatol, (in press).

    Google Scholar 

  10. D.M. Gibbs and J.D. Neill, Dopamine levels in hypophyseal stalk secretions in the rat are sufficient to inhibit prolactin secretion in vivo, Endocrinology 102:1895 (1978).

    Article  PubMed  CAS  Google Scholar 

  11. D.A. Leong, L.S. Frawley and J.D. Neill, Neuroendocrine controls of prolactin secretion, Annu. Rev. Physiol. 45:109 (1983).

    Article  PubMed  CAS  Google Scholar 

  12. D.H. Russell, D.F. Larson, S.B. Cardin and J.G. Copeland, Cyclosporine inhibits prolactin induction of ornithidine decarboxylase in rat tissues, Mol. Cell. Endocrinol. 35:159 (1984).

    Article  PubMed  CAS  Google Scholar 

  13. D.H. Russell, New aspects of prolactin and immunity: a lymphocyte-derived prolactin-like product and nuclear protein kinase C. activation, Trends Pharmacol. Sci. 10:40 (1989).

    Article  PubMed  CAS  Google Scholar 

  14. L.Y. Yu-Lee, A.M. Stevens, J.A. Hrachovy and L.A. Schwartz, Prolactin-mediated regulation of gene transcription in lymphocytes, Ann. N.Y. Acad. Sci. 594:146 (1990).

    Article  PubMed  CAS  Google Scholar 

  15. I. Berczi, E. Nagy, S. M. de Toledo, R. J. Matusik and H. G. Friesen, Pituitary hormones regulate c-myc and DNA synthesis in lymphoid tissue, J. Immunol. 146:2201 (1991).

    PubMed  CAS  Google Scholar 

  16. A.M. Stevens and L.Y. Yu-Lee, Regulation of interferon regulatory factor 1 (IRF-1) by prolatin in lymphocytes, Arthritis Rheum. 34(Suppl):S48 (1991).

    Article  Google Scholar 

  17. C.V. Clevenger, D.H. Russell, P.M. Appasamy and M.B. Prystowsky, Regulation of interleukin 2-driven T-lymphocyte proliferation by prolactin, Proc. Natl. Acad. Sci. USA 87:6460 (1990).

    Article  PubMed  CAS  Google Scholar 

  18. D.P. Hartmann, J.W. Holaday and E.W. Bernton, Inhibition of lymphocyte proliferation by antibodies to prolactin, FASEB J. 3:2194 (1989).

    PubMed  CAS  Google Scholar 

  19. E.W. Bernton, M.S. Meltzer and J.W. Holaday, Suppression of macrophage activation and T- lymphocyte function in hypoprolactinemic mice, Science 239:401 (1988).

    Article  PubMed  CAS  Google Scholar 

  20. E. Nagy and I. Berczi, Immunodeficiency in hypophysectomized rats, Acta Endocrinol. 89:530 (1978).

    PubMed  CAS  Google Scholar 

  21. R.J. Cross, J.L. Campbell and T.L. Roszman, Potentiation of antibody responsiveness after the transplantation of a syngeneic pituitary gland, J. Neuroimmunol. 25:29 (1989).

    Article  PubMed  CAS  Google Scholar 

  22. I. Berczi, E. Nagy, S.L. Asa and K. Kovacs, Pituitary hormones and contact sensitivity in rats, Allergy 38:325 (1983).

    Article  PubMed  CAS  Google Scholar 

  23. I. Berczi, E. Nagy, S.L. Asa and K. Kovacs, The influence of pituitary hormones on adjuvant arthritis, Arthritis Rheum. 27:682 (1984).

    Article  PubMed  CAS  Google Scholar 

  24. E. Nagy, I. Berczi, G.E. Wren, S.L. Asa and K. Kovacs, Immunomodulation by bromocriptine, Immunopharmacology 6:231 (1983).

    Article  PubMed  CAS  Google Scholar 

  25. P.N. Riskind, L. Massacesi, R.H. Doolittle and S.L. Häuser, The role of prolactin in autoimmune demyelination: suppression of experimental allergic encephalomyelitis by bromocriptine, Ann. Neurol. 29:542 (1991).

    Article  PubMed  CAS  Google Scholar 

  26. D.H. Russell, R. Kibler, L. Matrisian, D.F. Larson, B. Poulos and B.E. Magun, Prolactin receptors on human T and B lymphocytes: antagonism of prolactin binding by cyclosporine, J. Immunol. 134:3027 (1985).

    PubMed  CAS  Google Scholar 

  27. A.F. Nakhooda, A.A. Like, C.I. Chappel, C.N. Wei and E.B. Marliss, The spontaneously diabetic Wistar rat (the “BB” rat). Studies prior to and during development of the overt syndrome, Diabetologia 14:199 (1978).

    Article  PubMed  CAS  Google Scholar 

  28. J.L. Mahon, H.C. Gunn, K. Stobie, C. Gibson, B. Garcia, J. Dupre and C.R. Stiller, The effect of bromocriptine and cyclosporine on spontaneous diabetes in BB rats, Transplant. Proc. 20(suppl):197 (1988).

    PubMed  CAS  Google Scholar 

  29. A.G. Palestine, C.G. Muellenberg-Coulombre, M.K. Kim, M.C. Gelato and R.B. Nussenblatt, Bromocriptine and low dose cyclosporine in the treatment of experimental autoimmune uveitis in the rat, J. Clin. Invest. 79:1078 (1987).

    Article  PubMed  CAS  Google Scholar 

  30. A.D. Steinberg, T. Pincus and N. Talal, DNA-binding assay for detection of anti-DNA antibodies in NZB/NZW Fx mice, J. Immunol. 102:788 (1969).

    PubMed  CAS  Google Scholar 

  31. A.N. Theofilopoulos and F.J. Dixon, Experimental murine systemic lupus erythematosus, in: “Systemic Lupus Erythematosus,” R.G. Lahita, ed., John Wiley & Sons, New York (1987).

    Google Scholar 

  32. J. Roubinian, N. Talal, P.K. Siiteri and J.A. Sadakian, Sex hormone modulation of autoimmunity in NZB/NZW mice, Arthritis Rheum. 22:1162 (1979).

    PubMed  CAS  Google Scholar 

  33. K.A. Melez, W.A. Boegel and A.D. Steinberg, Therapeutic studies in New Zealand mice. VII. Successful androgen treatment of NZB/NZW Fx females of different ages, Arthritis Rheum. 12:41 (1980).

    Article  Google Scholar 

  34. J.R. Roubinian, N. Talal, J.S. Greenspan, J.R. Goodman and P.K. Siiteri, Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F x mice, J. Exp. Med. 147:1568 (1978).

    Article  PubMed  CAS  Google Scholar 

  35. J.R. Roubinian, R. Papoian and N. Talal, Androgenic hormones modulate autoantibody responses and improve survival in murine lupus, J. Clin. Invest. 59:1066 (1979).

    Article  Google Scholar 

  36. P.K. Siiteri, L.A. Jones, J. Roubinian and N. Talal, Sex steroids and the immune system-1. Sex difference in autoimmune disease in NZB/NZW hybrid mice, J. Steroid Biochem. 12:425 (1980).

    Article  PubMed  CAS  Google Scholar 

  37. S. E. Walker, R. W. McMurray, C. L. Besch-Williford, L. W. Keisler and D. H. Keisler, Exogenous 17-β-estradiol (E2) and ethinyl estradiol (EE) therapy in the NZB/W mouse model of systemic lupus erythematosus (SLE); disease modification, toxicity, and pituitary response, Lupus 1(suppl):18 (1992).

    Google Scholar 

  38. S.E. Walker, R.W. McMurray, C.L. Besch-Williford and D.H. Keisler, Premature death with bladder outlet obstruction and hyperprolactinemia in New Zealand Black X New Zealand White mice treated with ethinyl estradiol and 17-β-estradiol, Arthritis Rheum. 35:1387 (1992).

    PubMed  CAS  Google Scholar 

  39. H. Selye, On the toxicity of oestrogens with special reference to diethylstilbestrol, Can. Med. Assoc. J. 41:48 (1939).

    PubMed  CAS  Google Scholar 

  40. S. Franks, Regulation of prolactin secretion by oestrogens: physiological and pathological significance, Clin. Sci. 65:457 (1983).

    PubMed  CAS  Google Scholar 

  41. R.A. Adler, The anterior pituitary-grafted rat: a valid model of chronic hyperprolactinemia, Endocr. Rev. 7:302 (1986).

    Article  PubMed  CAS  Google Scholar 

  42. D. Wofsy, Administration of monoclonal anti-T cell antibodies retards murine lupus in BXSB mice, J. Immunol. 136:4554 (1986).

    PubMed  CAS  Google Scholar 

  43. D. Wofsy and W.E. Seaman, Reversal of advanced murine lupus in NZB/NZW Fj mice by treatment with monoclonal antibody to L3T4, J. Immunol. 138:3247 (1987).

    PubMed  CAS  Google Scholar 

  44. T.J. Santoro, J.P. Portanova and B.L. Kotzin, The contribution of L3T4+ cells to lymphoproliferation and autoantibody production in MRL-lpr/lpr mice, J. Exp. Med. 167:1713 (1988).

    Article  PubMed  CAS  Google Scholar 

  45. N.E. Street and T.R. Mosmann, Functional diversity of T lymphocytes due to secretion of different cytokine patterns, FASEB J. 5:171 (1991).

    PubMed  CAS  Google Scholar 

  46. T.J. Santoro, T.A. Luger, E.S. Raveche, J.S. Smolen, J.J. Oppenheim and A.D. Steinberg, In vitro correction of the interleukin 2 defect of autoimmune mice, Eur. J. Immunol. 13:601 (1983).

    Article  PubMed  CAS  Google Scholar 

  47. C.O. Jacob, P.H. van der Meide and H.O. McDevitt, In vivo treatment of (NZB X NZW) F1 lupus-like nephritis with monoclonal antibody to c interferon, J. Exp. Med. 166:798 (1987).

    Article  PubMed  CAS  Google Scholar 

  48. T.R. Mosmann, H. Cherwinsky, M.W. Bond, M.A. Giedlin and R.L. Coffman, Two types of murine helper T cell clones. I. Definition according to profiles of lymphokine activities and secreted proteins, J. Immunol. 136:2348 (1986).

    PubMed  CAS  Google Scholar 

  49. E.S. Vitetta, J. Ohara, C.D. Myers, J.E. Layton, P.H. Krammer and W.E. Paul, Serological, biochemical and functional identity of B cell-stimulatory factor 1 and B cell differentiation factor for IgGl, J. Exp. Med. 162:1726 (1985).

    Article  PubMed  CAS  Google Scholar 

  50. T. Kishimoto and T. Hirano, Molecular regulation of B lymphocyte response, Annu. Rev. Immunol. 6:485 (1988).

    Article  PubMed  CAS  Google Scholar 

  51. G.J. Prud’homme, C.L. Park, T.M. Fieser, R. Kofler, F J. Dixon and A.N. Theofilopoulos, Identification of a B cell differentiation factor(s) spontaneously produced by proliferating T cells in murine lupus strains of the lpr/lpr genotype, J. Exp. Med. 157:730 (1983).

    Article  PubMed  Google Scholar 

  52. N. Breslow, Covariance analysis of censored survival data, Biometrics 30:89 (1974).

    Article  PubMed  CAS  Google Scholar 

  53. S. Umland, R. Lee, M. Howard and C. Martens, Expression of lymphokine genes in splenic lymphocytes of autoimmune mice, Mol. Immunol. 26:649 (1989).

    Article  PubMed  CAS  Google Scholar 

  54. L.J. Murray, R. Lee and C. Martens, In vivo cytokine gene expression in T cell subsets of the autoimmune MRL/Mp-lpr/lpr mouse, Eur. J. Immunol. 20:163 (1990).

    Article  PubMed  CAS  Google Scholar 

  55. R.W. McMurray, R.W. Hoffman and S.E. Walker, In vivo prolactin manipulation alters in vitro IL-2, IL-4, and IFN-c mRNA levels in female B/W mice, Clin. Res. 39:734A (1991).

    Google Scholar 

  56. M. Linker-Israeli and R. Deant, Dysregulated lymphokine production in systemic lupus erythematosus (SLE), Ann. NY Acad. Sci. 557:567 (1989).

    Article  Google Scholar 

  57. C. Ferrari, M. Boghen, A. Paracchi, P. Rampini, F. Raiteri, R. Benco, M. Romussi, F. Codecasa, M. Mucci and M. Bianco, Thyroid autoimmunity in hyperprolactinemic disorders, Acta Endocrinol. 104:35 (1983).

    PubMed  CAS  Google Scholar 

  58. W.B. Malarkey, R. Jackson and J. Wortsman, Long-term assessment of patients with macroprolactinemia, Fértil. Steril. 50:413 (1988).

    PubMed  CAS  Google Scholar 

  59. A.G. Palestine, R.B. Nussenblatt and M. Gelato, Therapy for autoimmune uveitis with low-dose cyclosporine plus bromocriptine, Transplant. Proc. 20:131 (1988).

    PubMed  CAS  Google Scholar 

  60. M. Blank, A. Palestine, R. Nussenblatt and Y. Shoenfeld, Down-regulation of autoantibody levels of cyclosporine and bromocriptine treatment in patients with uveitis, Clin. Immunol. Immunopathol. 54:87 (1990).

    Article  PubMed  CAS  Google Scholar 

  61. L.P. Hedner and G. Bynke, Endogenous iridocyclitis relieved during treatment with bromocriptine, Am. J. Ophthalmol. 100:618 (1985).

    PubMed  CAS  Google Scholar 

  62. C. Lavalle, D. González-Barcena, A. Graef and A. Fraga, Gonadotropins pituitary secretion in systemic lupus erythematosus, Clin. Exp. Rheumatol. 2:163 (1984).

    PubMed  CAS  Google Scholar 

  63. L. Jara-Quezada, A. Graef and C. Lavalle, Prolactin and gonadal hormones during pregnancy in systemic lupus erythematosus, J. Rheumatol. 18:349 (1991).

    PubMed  CAS  Google Scholar 

  64. L.J. Jara, C. Gomez-Sanchez, L.H. Silveira, P. Martinez-Osuna, M. Seleznick, F.B. Vasey and L.R. Espinosa, Hyperprolactinemia in systemic lupus erythematosus: association with disease, Am. J. Med. Sci. 303:222 (1992).

    Article  PubMed  CAS  Google Scholar 

  65. C.E. Rabinovich, L.E. Schanberg and D.W. Kredich, Intravenous immunoglobulin and bromocriptine in the treatment of refractory neuropsychiatrie systemic lupus erythematosus, Arthritis Rheum. 33(suppl):R22 (1990).

    Google Scholar 

  66. C. Lavalle, E. Loyo, R. Paniagua, J.A. Bermudez, J. Herrera, A. Graef, D. González-Barcena and A. Fraga, Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus, J. Rheumatol. 14:268 (1987).

    PubMed  CAS  Google Scholar 

  67. M. Folomeev, T. Prokaeva, V. Nassonova, E. Nassonov, V. Masenko and N. Ovtraht, Prolactin levels in men with SLE and RA, J. Rheumatol. 17:1569 (1990).

    PubMed  CAS  Google Scholar 

  68. D.W. Montgomery, C.F. Zukoski, G.N. Shah, A.R. Buckley, T. Pacholczyk and D.H. Russell, Concanavalin A-stimulated murine splenocytes produce a factor with prolactin-like bioactivity and immunoreactivity, Biochem. Biophys. Res. Commun. 145:692 (1987).

    Article  PubMed  CAS  Google Scholar 

  69. G.E. DiMattia, B. Gellerson, H.G. Bohnet and H.G. Friesen, A human B-lymphoblastoid cell line produces prolactin, Endocrinology 122:2508 (1988).

    Article  Google Scholar 

  70. S.J. Hatfill, R. Kirby, M. Hanley, E. Rybicki and L. Böhm, Hyperprolactinemia in acute myeloid leukemia and indication of ectopic expression of human prolactin in blast cells of a patient of subtype M4, Leuk. Res. 14:57 (1990).

    Article  PubMed  CAS  Google Scholar 

  71. P. Sabharwal, R. Glaser, W. Lafuse, S. Varma, Q. Liu, S. Arkins, R. Kooijman, L. Kutz, K.W. Kelley and W.B. Malarkey, Prolactin synthesized and secreted by human peripheral bloo mononuclear cells: an autocrine growth factor for lymphoproliferation, Proc. Natl. Acad. Sci. USA 89:7713 (1992).

    Article  PubMed  CAS  Google Scholar 

  72. B.L. Spangelo, A.M. Judd, P.C. Isakson and R.M. MacLeod, IL-6 stimulates anterior pituitary hormone reíase in vitro, Endocrinology 125:575 (1989).

    Article  PubMed  CAS  Google Scholar 

  73. H. Vankelecom, P. Carmeliet, J. Van Damme and C. Denef, Production of interleukin-6 by follicuo-stellate cells of the anterior pituitary gland in a histiotypic cell aggregate culture system, Neuroendocrinology 49:102 (1989).

    Article  PubMed  CAS  Google Scholar 

  74. T.H. Jones, A. Price, S. Justice and K. Chapman, Interleukin-6 secretion by human pituitary adenomas in vitro, J. Endocrinol. 127(suppl):86 (1990).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer Science+Business Media New York

About this chapter

Cite this chapter

Walker, S.E., Keisler, D.H., Allen, S.H., Besch-Williford, C.L., Hoffman, R.W., McMurray, R.W. (1994). Prolactin and Autoimmunity: Influences of Prolactin in Systemic Lupus Erythematosus. In: Berczi, I., Szélenyi, J. (eds) Advances in Psychoneuroimmunology. Hans Selye Symposia on Neuroendocrinology and Stress, vol 3. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9104-4_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-9104-4_9

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-9106-8

  • Online ISBN: 978-1-4757-9104-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics